-
How does RWD improve market sizing research?
DRG Partner, Adrienne Lovink talks about how the application of Real World Data improves Market Sizing research. Transcript: The primary reason to consider using real-world data for market sizing...
-
How is RWD-based patient journey research helping medtech plan for the future?
In this video, Felix Lam, Associate Lead from DRG's Client Engagement Team, speaks about how the application of Real World Data in Patient Journey research is helping medtech plan for the future...
-
What is the value of pharma patient support resources?
Patient Engagement Insights What is the value of pharma patient support resources? PATIENT SUPPORT RESOURCES HELP TO... DIFFERENTIATE 59% don’t have a preference for a generic or branded medication...
-
KOL presentations at conferences still pack a punch
Physician Engagement Insights KOL presentations at conferences still pack a punch Record content for digital engagement after the event EU5 physician monthly participation and influence of conferences...
-
Why are Non-Clinical Stakeholders Important to Medtech Companies?
Transcript: We have been thinking about this in terms of the personnel that a medtech manufacturer needs to interact with as far as commercializing a product goes. In the past we know physicians...
-
How are Medtech Companies Adapting to Better Engage with Non-Clinical Stakeholders?
Transcript: The spectrum of the types of services, programs, resources that hospitals need today is definitely changing as well as the type of stakeholders that are involved. So, when we use the term...
-
How are Non-Clinical Stakeholder Needs Expected to Change in the Future?
Transcript: When I think about the future, I think we have identified two things that are important to think about: the first one being how can medtech manufacturers partner with hospitals to help...
-
CAR T-Cell Therapy: Development Boom in China
CAR T-Cell Therapy: Development Boom in China China’s biotech innovation is challenging the dominance of the United States Healthcare reforms and strategies which encourage innovation and biotech...
-
Integrated Patient Journey: One Journey, Many Lenses
Integrated Patient Journey One Journey, Many Lenses Download our executive brief to learn: How the patient journey has evolved and what’s driving the need for a more comprehensive view The different...
-
Medtech Regulatory Dynamics 2020: 6 Big Regulatory Updates and Takeaways for Medtech Teams
2020 is expected to be a particularly eventful year for global medtech markets; be it due to brand new regulations, challenges to existing healthcare systems, updated trade agreements, unique...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
